nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—SLCO1B3—Rifampicin—leprosy	0.162	0.184	CbGbCtD
Losartan—UGT1A1—Rifampicin—leprosy	0.136	0.155	CbGbCtD
Losartan—SLCO1B1—Rifampicin—leprosy	0.0945	0.107	CbGbCtD
Losartan—CYP3A5—Thalidomide—leprosy	0.0429	0.0488	CbGbCtD
Losartan—CYP3A5—Rifampicin—leprosy	0.0416	0.0472	CbGbCtD
Losartan—CYP2C8—Rifampicin—leprosy	0.04	0.0454	CbGbCtD
Losartan—CYP2C19—Thalidomide—leprosy	0.0346	0.0393	CbGbCtD
Losartan—CYP3A5—Dapsone—leprosy	0.0343	0.039	CbGbCtD
Losartan—CYP2C19—Rifampicin—leprosy	0.0335	0.0381	CbGbCtD
Losartan—CYP2C8—Dapsone—leprosy	0.033	0.0375	CbGbCtD
Losartan—CYP1A2—Thalidomide—leprosy	0.032	0.0363	CbGbCtD
Losartan—CYP1A2—Rifampicin—leprosy	0.0309	0.0352	CbGbCtD
Losartan—CYP2C9—Thalidomide—leprosy	0.0288	0.0327	CbGbCtD
Losartan—CYP2C9—Rifampicin—leprosy	0.0279	0.0317	CbGbCtD
Losartan—CYP2C19—Dapsone—leprosy	0.0277	0.0315	CbGbCtD
Losartan—ABCB1—Rifampicin—leprosy	0.0271	0.0307	CbGbCtD
Losartan—CYP2C9—Dapsone—leprosy	0.023	0.0261	CbGbCtD
Losartan—CYP3A4—Rifampicin—leprosy	0.0162	0.0184	CbGbCtD
Losartan—CYP3A4—Dapsone—leprosy	0.0134	0.0152	CbGbCtD
Losartan—Localized exfoliation—Dapsone—leprosy	0.00812	0.0728	CcSEcCtD
Losartan—Pain in arm—Thalidomide—leprosy	0.00682	0.0612	CcSEcCtD
Losartan—Sinus bradycardia—Thalidomide—leprosy	0.00228	0.0205	CcSEcCtD
Losartan—Skin exfoliation—Dapsone—leprosy	0.00209	0.0187	CcSEcCtD
Losartan—Toothache—Thalidomide—leprosy	0.00184	0.0165	CcSEcCtD
Losartan—Serum creatinine increased—Thalidomide—leprosy	0.00182	0.0163	CcSEcCtD
Losartan—Muscular weakness—Dapsone—leprosy	0.0014	0.0126	CcSEcCtD
Losartan—Influenza—Dapsone—leprosy	0.00137	0.0123	CcSEcCtD
Losartan—Pancreatitis—Dapsone—leprosy	0.00134	0.0121	CcSEcCtD
Losartan—Jaundice cholestatic—Thalidomide—leprosy	0.00127	0.0114	CcSEcCtD
Losartan—Photosensitivity reaction—Dapsone—leprosy	0.00125	0.0112	CcSEcCtD
Losartan—Musculoskeletal stiffness—Thalidomide—leprosy	0.00125	0.0112	CcSEcCtD
Losartan—Cellulitis—Thalidomide—leprosy	0.00123	0.011	CcSEcCtD
Losartan—Hyperuricaemia—Thalidomide—leprosy	0.00121	0.0108	CcSEcCtD
Losartan—Neuropathy peripheral—Dapsone—leprosy	0.0012	0.0108	CcSEcCtD
Losartan—Sinusitis—Dapsone—leprosy	0.00115	0.0103	CcSEcCtD
Losartan—Blood uric acid increased—Thalidomide—leprosy	0.00114	0.0102	CcSEcCtD
Losartan—Hyperkalaemia—Thalidomide—leprosy	0.0011	0.00986	CcSEcCtD
Losartan—Pharyngitis—Dapsone—leprosy	0.00109	0.00977	CcSEcCtD
Losartan—ACE—hindlimb—leprosy	0.00107	0.128	CbGeAlD
Losartan—Skin exfoliation—Thalidomide—leprosy	0.00107	0.00958	CcSEcCtD
Losartan—Blood urea increased—Thalidomide—leprosy	0.00106	0.00948	CcSEcCtD
Losartan—Aplastic anaemia—Thalidomide—leprosy	0.00105	0.00942	CcSEcCtD
Losartan—ACE—arm—leprosy	0.00102	0.123	CbGeAlD
Losartan—Tinnitus—Dapsone—leprosy	0.00102	0.00918	CcSEcCtD
Losartan—Pulmonary oedema—Thalidomide—leprosy	0.000996	0.00893	CcSEcCtD
Losartan—Erythema—Dapsone—leprosy	0.000956	0.00857	CcSEcCtD
Losartan—Diabetes mellitus—Thalidomide—leprosy	0.000934	0.00838	CcSEcCtD
Losartan—Photosensitivity—Thalidomide—leprosy	0.000925	0.0083	CcSEcCtD
Losartan—ACE—appendage—leprosy	0.00092	0.11	CbGeAlD
Losartan—Vascular purpura—Thalidomide—leprosy	0.000908	0.00815	CcSEcCtD
Losartan—Vision blurred—Dapsone—leprosy	0.000901	0.00808	CcSEcCtD
Losartan—Injury—Thalidomide—leprosy	0.000884	0.00793	CcSEcCtD
Losartan—Libido decreased—Thalidomide—leprosy	0.000876	0.00786	CcSEcCtD
Losartan—Dermatitis exfoliative—Thalidomide—leprosy	0.000861	0.00772	CcSEcCtD
Losartan—Vertigo—Dapsone—leprosy	0.000859	0.0077	CcSEcCtD
Losartan—Atrial fibrillation—Thalidomide—leprosy	0.000857	0.00769	CcSEcCtD
Losartan—Purpura—Thalidomide—leprosy	0.000843	0.00756	CcSEcCtD
Losartan—ACE—peripheral nervous system—leprosy	0.000837	0.1	CbGeAlD
Losartan—Arthritis—Thalidomide—leprosy	0.000836	0.0075	CcSEcCtD
Losartan—Cough—Dapsone—leprosy	0.000834	0.00748	CcSEcCtD
Losartan—Hypoglycaemia—Thalidomide—leprosy	0.000832	0.00747	CcSEcCtD
Losartan—Hyponatraemia—Thalidomide—leprosy	0.000816	0.00732	CcSEcCtD
Losartan—Pain in extremity—Thalidomide—leprosy	0.000812	0.00729	CcSEcCtD
Losartan—Disturbance in sexual arousal—Thalidomide—leprosy	0.000806	0.00723	CcSEcCtD
Losartan—Migraine—Thalidomide—leprosy	0.0008	0.00717	CcSEcCtD
Losartan—Face oedema—Thalidomide—leprosy	0.000784	0.00703	CcSEcCtD
Losartan—Ataxia—Thalidomide—leprosy	0.000764	0.00685	CcSEcCtD
Losartan—Tachycardia—Dapsone—leprosy	0.000761	0.00683	CcSEcCtD
Losartan—Blood creatinine increased—Thalidomide—leprosy	0.000761	0.00683	CcSEcCtD
Losartan—Dry skin—Thalidomide—leprosy	0.000745	0.00668	CcSEcCtD
Losartan—Orthostatic hypotension—Thalidomide—leprosy	0.000742	0.00666	CcSEcCtD
Losartan—Breast disorder—Thalidomide—leprosy	0.000734	0.00658	CcSEcCtD
Losartan—Cramp muscle—Thalidomide—leprosy	0.000732	0.00656	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000732	0.00656	CcSEcCtD
Losartan—Muscular weakness—Thalidomide—leprosy	0.000716	0.00643	CcSEcCtD
Losartan—Insomnia—Dapsone—leprosy	0.000705	0.00633	CcSEcCtD
Losartan—Influenza—Thalidomide—leprosy	0.000702	0.0063	CcSEcCtD
Losartan—Eosinophilia—Thalidomide—leprosy	0.000695	0.00624	CcSEcCtD
Losartan—AGTR1—blood vessel—leprosy	0.000694	0.083	CbGeAlD
Losartan—Pancreatitis—Thalidomide—leprosy	0.000688	0.00617	CcSEcCtD
Losartan—Angina pectoris—Thalidomide—leprosy	0.000684	0.00613	CcSEcCtD
Losartan—Bronchitis—Thalidomide—leprosy	0.000675	0.00606	CcSEcCtD
Losartan—Upper respiratory tract infection—Thalidomide—leprosy	0.000653	0.00585	CcSEcCtD
Losartan—ACE—nerve—leprosy	0.000652	0.0781	CbGeAlD
Losartan—Pollakiuria—Thalidomide—leprosy	0.000649	0.00582	CcSEcCtD
Losartan—Erectile dysfunction—Thalidomide—leprosy	0.000647	0.0058	CcSEcCtD
Losartan—Photosensitivity reaction—Thalidomide—leprosy	0.000641	0.00575	CcSEcCtD
Losartan—Weight increased—Thalidomide—leprosy	0.000639	0.00573	CcSEcCtD
Losartan—Gastrointestinal pain—Dapsone—leprosy	0.000638	0.00572	CcSEcCtD
Losartan—Hyperglycaemia—Thalidomide—leprosy	0.000633	0.00568	CcSEcCtD
Losartan—Pneumonia—Thalidomide—leprosy	0.00063	0.00565	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000621	0.00557	CcSEcCtD
Losartan—Body temperature increased—Dapsone—leprosy	0.000617	0.00553	CcSEcCtD
Losartan—Abdominal pain—Dapsone—leprosy	0.000617	0.00553	CcSEcCtD
Losartan—Renal failure—Thalidomide—leprosy	0.000615	0.00552	CcSEcCtD
Losartan—Neuropathy peripheral—Thalidomide—leprosy	0.000614	0.0055	CcSEcCtD
Losartan—Conjunctivitis—Thalidomide—leprosy	0.000609	0.00546	CcSEcCtD
Losartan—Sweating—Thalidomide—leprosy	0.0006	0.00538	CcSEcCtD
Losartan—Epistaxis—Thalidomide—leprosy	0.00059	0.0053	CcSEcCtD
Losartan—Sinusitis—Thalidomide—leprosy	0.000587	0.00527	CcSEcCtD
Losartan—Agranulocytosis—Thalidomide—leprosy	0.000584	0.00524	CcSEcCtD
Losartan—Rhinitis—Thalidomide—leprosy	0.000563	0.00505	CcSEcCtD
Losartan—Hepatitis—Thalidomide—leprosy	0.000562	0.00504	CcSEcCtD
Losartan—Hypoaesthesia—Thalidomide—leprosy	0.000559	0.00502	CcSEcCtD
Losartan—Pharyngitis—Thalidomide—leprosy	0.000558	0.005	CcSEcCtD
Losartan—Erythema multiforme—Thalidomide—leprosy	0.000531	0.00477	CcSEcCtD
Losartan—SLC2A9—testis—leprosy	0.000528	0.0632	CbGeAlD
Losartan—Tinnitus—Thalidomide—leprosy	0.000524	0.0047	CcSEcCtD
Losartan—ACE—blood vessel—leprosy	0.000512	0.0613	CbGeAlD
Losartan—Angiopathy—Thalidomide—leprosy	0.00051	0.00457	CcSEcCtD
Losartan—Arrhythmia—Thalidomide—leprosy	0.000502	0.0045	CcSEcCtD
Losartan—Alopecia—Thalidomide—leprosy	0.000497	0.00445	CcSEcCtD
Losartan—Vomiting—Dapsone—leprosy	0.000496	0.00445	CcSEcCtD
Losartan—Headache—Dapsone—leprosy	0.000489	0.00438	CcSEcCtD
Losartan—Flatulence—Thalidomide—leprosy	0.000482	0.00432	CcSEcCtD
Losartan—Tension—Thalidomide—leprosy	0.00048	0.00431	CcSEcCtD
Losartan—Dysgeusia—Thalidomide—leprosy	0.000479	0.0043	CcSEcCtD
Losartan—Nervousness—Thalidomide—leprosy	0.000475	0.00426	CcSEcCtD
Losartan—Back pain—Thalidomide—leprosy	0.000473	0.00424	CcSEcCtD
Losartan—Muscle spasms—Thalidomide—leprosy	0.00047	0.00422	CcSEcCtD
Losartan—Nausea—Dapsone—leprosy	0.000463	0.00416	CcSEcCtD
Losartan—Vision blurred—Thalidomide—leprosy	0.000461	0.00414	CcSEcCtD
Losartan—Tremor—Thalidomide—leprosy	0.000458	0.00411	CcSEcCtD
Losartan—Ill-defined disorder—Thalidomide—leprosy	0.000454	0.00407	CcSEcCtD
Losartan—Anaemia—Thalidomide—leprosy	0.000452	0.00406	CcSEcCtD
Losartan—Agitation—Thalidomide—leprosy	0.00045	0.00403	CcSEcCtD
Losartan—Angioedema—Thalidomide—leprosy	0.000447	0.00401	CcSEcCtD
Losartan—Malaise—Thalidomide—leprosy	0.000441	0.00396	CcSEcCtD
Losartan—Vertigo—Thalidomide—leprosy	0.00044	0.00394	CcSEcCtD
Losartan—Syncope—Thalidomide—leprosy	0.000439	0.00394	CcSEcCtD
Losartan—Leukopenia—Thalidomide—leprosy	0.000438	0.00393	CcSEcCtD
Losartan—Palpitations—Thalidomide—leprosy	0.000432	0.00388	CcSEcCtD
Losartan—Loss of consciousness—Thalidomide—leprosy	0.00043	0.00386	CcSEcCtD
Losartan—Cough—Thalidomide—leprosy	0.000427	0.00383	CcSEcCtD
Losartan—Myalgia—Thalidomide—leprosy	0.000417	0.00374	CcSEcCtD
Losartan—Chest pain—Thalidomide—leprosy	0.000417	0.00374	CcSEcCtD
Losartan—Arthralgia—Thalidomide—leprosy	0.000417	0.00374	CcSEcCtD
Losartan—Anxiety—Thalidomide—leprosy	0.000415	0.00372	CcSEcCtD
Losartan—Discomfort—Thalidomide—leprosy	0.000412	0.00369	CcSEcCtD
Losartan—Dry mouth—Thalidomide—leprosy	0.000407	0.00365	CcSEcCtD
Losartan—Confusional state—Thalidomide—leprosy	0.000403	0.00361	CcSEcCtD
Losartan—Oedema—Thalidomide—leprosy	0.000399	0.00358	CcSEcCtD
Losartan—Infection—Thalidomide—leprosy	0.000397	0.00356	CcSEcCtD
Losartan—Shock—Thalidomide—leprosy	0.000393	0.00352	CcSEcCtD
Losartan—Nervous system disorder—Thalidomide—leprosy	0.000392	0.00351	CcSEcCtD
Losartan—Thrombocytopenia—Thalidomide—leprosy	0.000391	0.00351	CcSEcCtD
Losartan—Tachycardia—Thalidomide—leprosy	0.00039	0.0035	CcSEcCtD
Losartan—Hyperhidrosis—Thalidomide—leprosy	0.000386	0.00346	CcSEcCtD
Losartan—Anorexia—Thalidomide—leprosy	0.000381	0.00341	CcSEcCtD
Losartan—Hypotension—Thalidomide—leprosy	0.000373	0.00335	CcSEcCtD
Losartan—Musculoskeletal discomfort—Thalidomide—leprosy	0.000364	0.00326	CcSEcCtD
Losartan—Insomnia—Thalidomide—leprosy	0.000361	0.00324	CcSEcCtD
Losartan—Paraesthesia—Thalidomide—leprosy	0.000359	0.00322	CcSEcCtD
Losartan—Dyspnoea—Thalidomide—leprosy	0.000356	0.00319	CcSEcCtD
Losartan—Somnolence—Thalidomide—leprosy	0.000355	0.00318	CcSEcCtD
Losartan—Dyspepsia—Thalidomide—leprosy	0.000351	0.00315	CcSEcCtD
Losartan—Decreased appetite—Thalidomide—leprosy	0.000347	0.00311	CcSEcCtD
Losartan—Fatigue—Thalidomide—leprosy	0.000344	0.00309	CcSEcCtD
Losartan—Constipation—Thalidomide—leprosy	0.000341	0.00306	CcSEcCtD
Losartan—Pain—Thalidomide—leprosy	0.000341	0.00306	CcSEcCtD
Losartan—Feeling abnormal—Thalidomide—leprosy	0.000329	0.00295	CcSEcCtD
Losartan—Gastrointestinal pain—Thalidomide—leprosy	0.000326	0.00293	CcSEcCtD
Losartan—Urticaria—Thalidomide—leprosy	0.000317	0.00285	CcSEcCtD
Losartan—Abdominal pain—Thalidomide—leprosy	0.000316	0.00283	CcSEcCtD
Losartan—Body temperature increased—Thalidomide—leprosy	0.000316	0.00283	CcSEcCtD
Losartan—Hypersensitivity—Thalidomide—leprosy	0.000294	0.00264	CcSEcCtD
Losartan—Asthenia—Thalidomide—leprosy	0.000286	0.00257	CcSEcCtD
Losartan—Pruritus—Thalidomide—leprosy	0.000282	0.00253	CcSEcCtD
Losartan—Diarrhoea—Thalidomide—leprosy	0.000273	0.00245	CcSEcCtD
Losartan—UGT2B7—testis—leprosy	0.000273	0.0327	CbGeAlD
Losartan—ACE—eye—leprosy	0.000273	0.0326	CbGeAlD
Losartan—Dizziness—Thalidomide—leprosy	0.000264	0.00237	CcSEcCtD
Losartan—Vomiting—Thalidomide—leprosy	0.000254	0.00228	CcSEcCtD
Losartan—Rash—Thalidomide—leprosy	0.000252	0.00226	CcSEcCtD
Losartan—Dermatitis—Thalidomide—leprosy	0.000252	0.00226	CcSEcCtD
Losartan—Headache—Thalidomide—leprosy	0.00025	0.00224	CcSEcCtD
Losartan—AGTR1—tendon—leprosy	0.000245	0.0293	CbGeAlD
Losartan—Nausea—Thalidomide—leprosy	0.000237	0.00213	CcSEcCtD
Losartan—AGTR1—testis—leprosy	0.000202	0.0242	CbGeAlD
Losartan—AGTR1—nervous system—leprosy	0.000199	0.0238	CbGeAlD
Losartan—ABCB1—blood vessel—leprosy	0.00018	0.0216	CbGeAlD
Losartan—ALB—testis—leprosy	0.000156	0.0187	CbGeAlD
Losartan—ACE—testis—leprosy	0.000149	0.0179	CbGeAlD
Losartan—ACE—nervous system—leprosy	0.000147	0.0176	CbGeAlD
Losartan—CYP2C8—testis—leprosy	0.00011	0.0131	CbGeAlD
Losartan—CYP3A4—nervous system—leprosy	7.3e-05	0.00873	CbGeAlD
Losartan—ABCB1—testis—leprosy	5.26e-05	0.0063	CbGeAlD
Losartan—ABCB1—nervous system—leprosy	5.17e-05	0.00618	CbGeAlD
